These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27318894)

  • 21. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B; Angaji SA; Abolhasani M
    BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer.
    Matin F; Jeet V; Srinivasan S; Cristino AS; Panchadsaram J; Clements JA; Batra J;
    Clin Chem; 2019 Jun; 65(6):771-780. PubMed ID: 31018918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations of the MSR1 gene in prostate cancer families from Germany.
    Maier C; Vesovic Z; Bachmann N; Herkommer K; Braun AK; Surowy HM; Assum G; Paiss T; Vogel W
    Hum Mutat; 2006 Jan; 27(1):98-102. PubMed ID: 16287155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
    Chen C; Xin Z
    Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population.
    Kotarac N; Dobrijevic Z; Matijasevic S; Savic-Pavicevic D; Brajuskovic G
    Pathol Oncol Res; 2020 Oct; 26(4):2409-2423. PubMed ID: 32556890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikarein-related peptidase 3 common genetic variant and the risk of prostate cancer.
    Motamedi RK; Sarhangi N; Afshari M; Sattari M; Jamaldini SH; Samzadeh M; Mohsen Ziaei SA; Pourmand GR; Hasanzad M
    J Cell Biochem; 2019 Sep; 120(9):14822-14830. PubMed ID: 31017705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
    Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
    Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
    Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J
    Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
    Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
    Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
    Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
    BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between genetic polymorphisms of macrophage scavenger receptor 1 gene and risk of prostate cancer in the health professionals follow-up study.
    Chen YC; Giovannucci E; Kraft P; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):1001-3. PubMed ID: 18398045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
    Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
    Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
    Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
    Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.
    Chen YC; Giovannucci E; Kraft P; J Hunter D
    Carcinogenesis; 2008 May; 29(5):999-1004. PubMed ID: 18375959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
    Severi G; Giles GG; Southey MC; Tesoriero A; Tilley W; Neufing P; Morris H; English DR; McCredie MR; Boyle P; Hopper JL
    J Natl Cancer Inst; 2003 Jun; 95(11):818-24. PubMed ID: 12783937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of TRZ1, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z.
    Chen Y; Beck A; Davenport C; Chen Y; Shattuck D; Tavtigian SV
    BMC Mol Biol; 2005 May; 6():12. PubMed ID: 15892892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation in RNASEL associated with prostate cancer risk and progression.
    Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
    Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No association of germline alteration of MSR1 with prostate cancer risk.
    Wang L; McDonnell SK; Cunningham JM; Hebbring S; Jacobsen SJ; Cerhan JR; Slager SL; Blute ML; Schaid DJ; Thibodeau SN
    Nat Genet; 2003 Oct; 35(2):128-9. PubMed ID: 12958598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.